Все публикации

0:01:23

Dr Timothy Yap Reiterates the Unmet Medical Need for Molecularly Targeted Agents in Solid Tumors

0:00:58

Dr Andre Goy Discusses What We’ve Learned About CAR T Therapies and Cytokine Responses

0:05:18

Dr Javed Butler on SGLT-2 Inhibitors' Role in Preventing HF

0:02:55

Dyslipidemia: Strategies Used to Reduce CV Risk

0:06:02

Risk Assessment for Cardiovascular Disease

0:03:37

Optimal Management of CTEPH

0:06:39

CTD-PAH: Overview of Treatment Strategies

0:06:45

Identifying Connective Tissue Disease—Associated PAH

0:04:47

An Overview of PH and PAH

0:05:19

Drug Therapy & Liver Transplant for Advanced Fibrosis/NASH

0:06:28

Reversing Advanced Fibrosis Caused by NASH

0:05:52

Burden of Advanced Fibrosis Caused by NASH

0:03:32

Advanced Fibrosis in NASH: Patient Management

0:04:15

Noninvasive Testing in Advanced Fibrosis Due to NASH

0:05:22

Liver Biopsy in Advanced Fibrosis Due to NASH

0:04:17

Methods to Diagnose Advanced Fibrosis Due to NASH

0:04:43

Treating COPD With Combination Therapy

0:06:33

Opportunities to Optimize Care in COPD

0:05:19

Treatment Options for Diabetic Retinopathy

0:05:03

Triple Therapy in COPD: IMPACT and FULFIL

0:03:24

Triple Therapy for COPD

0:02:11

NASH and Advanced Fibrosis: Risk Factors

0:03:51

Practical Advice and the Future of Wound Care

0:07:58

Coverage of Combination Regimens for COPD